ProfileGDS4718 / 228336_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 88% 89% 87% 90% 87% 89% 88% 89% 91% 86% 90% 86% 86% 87% 88% 91% 84% 87% 89% 88% 87% 90% 86% 91% 85% 86% 90% 91% 88% 87% 88% 89% 88% 92% 87% 91% 87% 88% 89% 89% 88% 89% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2741783
GSM549102patient 115, normal, homogenized [OPG study]8.836288
GSM549104patient 119, normal, homogenized [OPG study]9.0099989
GSM549108patient 138, normal, homogenized [OPG study]8.6060987
GSM549119patient 077, normal, homogenized [OPG study]9.1797890
GSM549133patient 032, cancer, homogenized [OPG study]8.8497187
GSM549139patient 042, cancer, homogenized [OPG study]9.0537489
GSM549099patient 107, normal, homogenized [OPG study]8.7651788
GSM549109patient 139, normal, homogenized [OPG study]9.049889
GSM549110patient 046, normal, homogenized [OPG study]9.3900491
GSM549114patient 063, normal, homogenized [OPG study]8.6663386
GSM549122patient 082, normal, homogenized [OPG study]9.1981690
GSM549134patient 033, cancer, homogenized [OPG study]8.6823486
GSM549136patient 036, cancer, homogenized [OPG study]8.7356886
GSM549140patient 044, cancer, homogenized [OPG study]8.8541287
GSM549111patient 047, normal, homogenized [OPG study]8.925188
GSM549113patient 057, normal, homogenized [OPG study]9.6257291
GSM549132patient 031, cancer, homogenized [OPG study]8.3906584
GSM549137patient 038, cancer, homogenized [OPG study]8.7491987
GSM549142patient 047, cancer, homogenized [OPG study]8.5617689
GSM549100patient 110, normal, homogenized [OPG study]8.9194988
GSM549107patient 135, normal, homogenized [OPG study]8.8267587
GSM549115patient 068, normal, homogenized [OPG study]9.4488590
GSM549116patient 072, normal, homogenized [OPG study]8.7425286
GSM549120patient 078, normal, homogenized [OPG study]9.3618591
GSM549131patient 030, cancer, homogenized [OPG study]8.548585
GSM549118patient 074, normal, homogenized [OPG study]8.6910486
GSM549129patient 027, cancer, homogenized [OPG study]9.0526190
GSM549123patient 088, normal, homogenized [OPG study]9.4434691
GSM549124patient 006, cancer, homogenized [OPG study]8.7218588
GSM549126patient 015, cancer, homogenized [OPG study]8.7009687
GSM549128patient 025, cancer, homogenized [OPG study]8.9654388
GSM549103patient 117, normal, homogenized [OPG study]8.9786189
GSM549117patient 073, normal, homogenized [OPG study]9.0668888
GSM549138patient 041, cancer, homogenized [OPG study]9.4691992
GSM549141patient 045, cancer, homogenized [OPG study]8.8575687
GSM549130patient 028, cancer, homogenized [OPG study]9.1824891
GSM549101patient 111, normal, homogenized [OPG study]8.7037687
GSM549105patient 128, normal, homogenized [OPG study]8.8138588
GSM549106patient 134, normal, homogenized [OPG study]9.1260289
GSM549112patient 048, normal, homogenized [OPG study]9.1527689
GSM549125patient 011, cancer, homogenized [OPG study]8.8473488
GSM549127patient 024, cancer, homogenized [OPG study]8.8946789
GSM549135patient 035, cancer, homogenized [OPG study]9.0237288